Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: Where to go?

Clinical and Experimental Immunology

Volumn 164, Issue SUPPL. 1, 2011, Pages 1-3

  Kallenberg, C G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ANCA associated vasculitis; Myeloperoxidase ANCA; Pathogenesis; Proteinase 3 ANCA; Treatment

Indexed keywords

AUTOANTIGEN; BIOLOGICAL MARKER; CORTICOSTEROID; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; SILICON DIOXIDE;

ANCA ASSOCIATED VASCULITIS; BACTERIAL COLONIZATION; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; ENVIRONMENTAL FACTOR; EPIGENETICS; FOLLOW UP; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; IMMUNE COMPLEX NEPHRITIS; IMMUNOPATHOGENESIS; MORBIDITY; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SECONDARY PREVENTION; STAPHYLOCOCCUS AUREUS;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; HUMANS; MYELOBLASTIN; PEROXIDASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79953145916     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04355.x     Document Type: Review

References (15)

1. Chen M, Kallenberg CGM. ANCA-associated vasculitides - advances in pathgenesis and treatment. Nat Rev Rheumatol 2010; 6:653-64.
2. Falk RJ, Jennette JC. ANCA disease: where is this field heading? J Am Soc Nephrol 2010; 21:745-52.
3. Hunder GG, Arend WP, Bloch DA etal. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990; 33:1065-7.
4. Jennette JC, Falk RJ, Andrassy K etal. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-92.
5. Kallenberg CGM. Autoantibodies as biomarkers for ANCA-associated vasculitides. Curr Immunol Rev 2011; in press.
6. Cartin-Ceba R, Golbin J, Keogh KA etal. Rituximab for remission induction and maintenance in ANCA-associated vasculitis: a single-center ten-year experience in 108 patients. Arthritis Rheum 2010; 62:S283-4.
7. Kain R, Exner M, Brandes R etal. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008; 14:1088-96.
8. McKinney EF, Lyons PA, Carr EJ etal. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med 2010; 16:586-91.
9. Ciavatta DJ, Yang J, Preston GA etal. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest 2010; 120:3209-19.
10. Chen M, Yu F, Zhang Y etal. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int 2005; 68:2225-9.
11. Popa ER, Stegeman CA, Kallenberg CGM, Tervaert JW. Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res 2002; 4:77-9.
12. Pendergraft WF, Preston GA, Shah RR etal. Autoimmunity is triggered by cPR- (105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004; 10:72-9.
13. Berden AE, Kallenberg CGM, Savage COS etal. Cellular immunity in Wegener's granulomatosis. Characterizing T lymphocytes. Arthritis Rheum 2009; 60:1578-87.
14. Huugen D, van Esch A, Xiao H etal. Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int 2007; 71:646-54.
15. Abdulahad WH, Kallenberg CGM, Limburg PC, Stegeman CA. Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009; 60:2830-8.